Metric Finance
LearnFAQ
LearnFAQ

Learn / SLBT

NASDAQ: SLBT

SL Science Holding Ltd (SLBT) stock, explained like you're 5

SL Science Holding Ltd trades on the Nasdaq under the ticker SLBT. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 847 million dollars.

Ticker
SLBT
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 847 million dollars

Is SL Science Holding Ltd a small, medium or large cap company?

No. SL Science Holding Ltd is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 847 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How SL Science Holding Ltd makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SLBT stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • symbol__ Stock Quote Price and Forecast (CNN)
  • SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall (Yahoo Finance)
  • SLBT: SL Science Holding Limited Ordinary Shares Latest Stock Price, Analysis, News and Trading Ideas (Stocktwits)
  • A CEO buys shares without changing his total ownership in SL Science Holding (SLBT). (Stock Titan)
  • SLBT Stock Whipsaws As Volatility Attracts Active Traders (StocksToTrade)

Follow SLBT in your daily brief

Each trading day at 5 PM ET we post what happened to SL Science Holding Ltd and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SLBT

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about SL Science Holding Ltd stock

What does SL Science Holding Ltd do?

SL Science Holding Ltd trades on the Nasdaq under the ticker SLBT. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 847 million dollars.

What is the ticker symbol for SL Science Holding Ltd?

SL Science Holding Ltd trades under the ticker SLBT on the Nasdaq.

What is SL Science Holding Ltd's market cap?

SL Science Holding Ltd is a small cap stock with a market cap of about 847 million dollars.

How does SL Science Holding Ltd make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SLBT stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SLBT stock every day?

Add SLBT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SLBT daily

A free brief on SL Science Holding Ltd and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare SLBT: SLBT vs ARGX, SLBT vs RVMD, SLBT vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed